Clover Announces Positive Phase Ⅰ Results for SCB-219M for Treatment of Chemotherapy-Induced Thrombocytopenia (CIT)
PR Newswire Asia
--All CIT patients maintained platelet counts >75 x 10^9/L at 1-week following chemotherapy plus a single dose of SCB-219M, with..